You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

xyosted (autoinjector) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Xyosted (autoinjector), and when can generic versions of Xyosted (autoinjector) launch?

Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. There are twenty-three patents protecting this drug.

This drug has ninety-seven patent family members in fourteen countries.

The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Xyosted (autoinjector)

A generic version of xyosted (autoinjector) was approved as testosterone enanthate by NEXUS on June 14th, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for xyosted (autoinjector)?
  • What are the global sales for xyosted (autoinjector)?
  • What is Average Wholesale Price for xyosted (autoinjector)?
Drug patent expirations by year for xyosted (autoinjector)
Pharmacology for xyosted (autoinjector)
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for xyosted (autoinjector)

xyosted (autoinjector) is protected by twenty-three US patents.

Patents protecting xyosted (autoinjector)

Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Injection device with cammed RAM assembly
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Testosterone ester triglyceride formulations
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Needle assisted injection device having reduced trigger force
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Injection device with cammed ram assembly
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Needle assisted injection administration of testosterone compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Hematocrit modulation through needle assisted jet injection of testosterone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Syringe shock absorber for use in an injection device
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Prefilled syringe jet injector
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for xyosted (autoinjector)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 ⤷  Sign Up ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 ⤷  Sign Up ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-001 Sep 28, 2018 ⤷  Sign Up ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 ⤷  Sign Up ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 ⤷  Sign Up ⤷  Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-001 Sep 28, 2018 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for xyosted (autoinjector)

See the table below for patents covering xyosted (autoinjector) around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 3675868 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2006079064 ⤷  Sign Up
Hungary E042286 ⤷  Sign Up
Hungary E066268 ⤷  Sign Up
Canada 2900672 DISPOSITIF D'INJECTION A JET ASSISTEE PAR AIGUILLE AYANT UNE FORCE DE DECLENCHEMENT REDUITE (NEEDLE ASSISTED JET INJECTION DEVICE HAVING REDUCED TRIGGER FORCE) ⤷  Sign Up
Israel 184765 PREFILLED NEEDLE ASSISTED JET INJECTOR ⤷  Sign Up
South Korea 20120028294 HAZARDOUS AGENT INJECTION SYSTEM ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.